Case Studies on Drug Development and Novel Targets from Glenmark Pharmaceuticals and Novartis at COPD 2016

SMi Group reports: Glenmark Pharmaceuticals and Novartis Pharma to join the speaker line up at this years’ COPD conference in London on 19-20th October. [PR.com]

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us